McNeil launches dissolvable Zyrtec tablets
FORT WASHINGTON, Pa. — McNeil Consumer Healthcare recently introduced a new form to the Zyrtec portfolio of allergy-relief products — an oral, dissolvable tablet. Delivering the same effective 24-hour relief, Zyrtec Dissolve Tabs contains 10 mg of citrus-flavored cetirizine that melts in the mouth.
Mucinex enters allergy market
PARSIPPANY, N.J. — Reckitt Benckiser recently line-extended its Mucinex franchise into the year-round allergy sector with Mucinex Allergy. “More than 75% of Mucinex users also take an allergy treatment,” said Heather Allen, Reckitt Benckiser EVP category development. Mucinex Allergy is formulated with fexofenadine hydrochloride, the generic equivalent to Allegra, a $200 million brand.
Clear Eyes ranked leading allergy remedy
TARRYTOWN, N.Y. — It was one year ago that Prestige Brands announced Vanessa Williams would headline its Clear Eyes brand. And in the past year, the Clear Eyes franchise has grown 5.3% to $51.4 million for the 52 weeks ended April 20 across total U.S. multi-outlets, according to IRI. That ranks Clear Eyes No. 10 on a list of leading allergy remedies.
RELATED NEWS
You have 3 seconds
Dan Mack offers five strategies for making a meaningful first impression.Read more
CVS Health’s Be the First effort enters third year
The five-year, $50 million effort from the Woonsocket, R.I-based company aims to create the first tobacco-free generation.Read more
Store brands post strong performance across mass outlets
During 2017, store brand sales across all outlets measured by Nielsen came in at $122.3 billion, up 2.7% from $119.1 billion, while units moved up 1.6% to 44.6 billion from 43.9 billion.Read more
CVS Health ranks on Fast Company’s list of innovators
The Woonsocket, R.I.-based healthcare company was ranked seventh on the Fast Company list of the 50 Most Innovative Companies, as well as No. 1 on its Top 10 Most Innovative Companies in Health list.Read more
GNC enters China through joint venture with Hayao
As part of its joint venture with GNC, Hayao will take an approximate 40% stake in GNC with a $300 million investment.Read more
- facebook
- twitter
- linkedin
- envelope
- print
keyboard_arrow_downCOMMENTSNo comments found